Harrow
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Tennessee, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1a Burton Hills Blvd 200, Nashville, Ten...Phone Number
(615) 733-4730Website
www.harrow.comRevenue
$268.7 MillionStock Symbol
HROWIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Harrow
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, andRead more
Harrow Org Chart
CP
Director, Marketing
RM
Art Director
KD
Associate Director, Marketing Anterior
KG
Associate Director, Marketing Posterior Portf...
LK
Associate Director, Marketing
LA
Marketing Associate & Director
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Harrow your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Harrow
Check out if Harrow is spiking on competitors!
Product Launch: Get notified when Harrow launches new products
Funding: Get notified immidiatlly once Harrow has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Harrow had a recent Job posting/layoffs
Check if Harrow has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Harrow recently announced quarterly report
Harrow, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Harrow
Compare insights from companies similar to Harrow, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Harrow is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Harrow is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Harrow.
Harrow financials insights
Gather financial insights about Harrow, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
2023
Debt
$112.5M
Harrow Tech Stack
A closer look at the technologies used by Harrow
Most Recent Scoops
Open Position
Person-Based
Earnings, Finance, Investor Relations
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Earnings, Finance
Open Position
Harrow News & Media
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
NASHVILLE, Tenn., May 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will present at William Blair’s 46th Annual Growth Stock Conference on Wednesday, June 3, 2026, at 8:40 AM CT, in Chicago, IL.HROW Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Harrow for Potential Securities Law Violations
We are investigating Harrow Inc. for potential securities law violations following an over 23% drop in the stock price on May 12, 2026.Harrow Announces First Quarter 2026 Financial Results
First Quarter 2026 and Selected Highlights:Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026
Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on May 12, 2026 Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on May 12, 2026
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Harrow
Sign Up For FreeTo access detailed company insights
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE,... Read More
